VDAC, a multi-functional mitochondrial protein regulating cell life and death
People who used the medications also exhibited reduced risk for other adverse outcomes, including sickle cell crisis, venous thromboembolism, ischemic stroke or transient ischemic attack, and cardiopulmonary complications
Bordbar A et al (2017) Elucidating dynamic metabolic physiology through network integration of quantitative time-course metabolomics
GLP-1 drugs have the potential to disrupt that model, because users are not simply eating less, they are eating differently. YouGov research suggests consumers using the drugs are increasing their intake of vegetables, vitamins and fish or seafood by up to 38%
The principle remains intellectually compelling and mechanistically supported, but clinical demonstration of superiority based on signaling bias alone has yet to be robustly established for most peptide targets